Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Halozyme Therapeutics Inc
NASDAQ:HALO
Halozyme Therapeutics Inc
NASDAQ:HALO
Price:
131.43
USD
1.08%
Market Closed
Market Cap:
$15.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
US |
|
Lefroy Exploration Ltd
ASX:LEX
|
VG |
|
R
|
Ross Stores Inc
BMV:ROST
|
US |
|
Waskita Beton Precast Tbk PT
IDX:WSBP
|
ID |
|
MP Materials Corp
NYSE:MP
|
US |
|
Y
|
Yancoal Australia Ltd
OTC:YACAF
|
AU |
|
AAK AB (publ)
STO:AAK
|
SE |
|
C
|
Cleveland-Cliffs Inc
F:CVA
|
US |
|
Nel ASA
F:D7GA
|
NO |
|
Mohit Industries Ltd
BSE:531453
|
IN |
|
Neste Oyj
OTC:NTOIF
|
FI |
Wall St Price Targets
HALO Price Forecast
Based on 12 analysts
Based on 12 analysts
-15% Downside
from
$131.43
today
Halozyme Therapeutics Inc (HALO)’s 12-month stock price forecast through October 2027 has a consensus target of $111.86, implying 15% downside. The forecast is based on price targets from 12 Wall Street analysts.
HALO Analyst Rating
Based on 9 analysts
Based on 9 analysts
Analysts rate HALO Buy, with 7 of 9 recommending Buy or Strong buy.
Halozyme Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HALO's stock price target?
Price Target
111.86
USD
111.86
USD
According to Wall Street analysts, the average 1-year price target for HALO is 111.86 USD with a low forecast of 78.78 USD and a high forecast of 136.5 USD.
What is the Revenue forecast for Halozyme Therapeutics Inc?
Projected CAGR
0%
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 8 years is 0%.
What is the Gross Profit forecast for Halozyme Therapeutics Inc?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 3 years is 20%.
What is the Operating Income forecast for Halozyme Therapeutics Inc?
Projected CAGR
-7%
-7%
The compound annual growth rate for Operating Income over the next 8 years is -7%.
What is the Pre-Tax Income forecast for Halozyme Therapeutics Inc?
Projected CAGR
48%
48%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 48%.
What is the Net Income forecast for Halozyme Therapeutics Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Net Income over the next 8 years is 9%.